Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $96,449 | 43 | 52.2% |
| Consulting Fee | $54,252 | 27 | 29.3% |
| Travel and Lodging | $27,765 | 76 | 15.0% |
| Food and Beverage | $5,916 | 90 | 3.2% |
| Unspecified | $425.00 | 1 | 0.2% |
| Education | $99.00 | 1 | 0.1% |
| Gift | $17.99 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $105,623 | 121 | $0 (2021) |
| Vertex Pharmaceuticals Incorporated | $28,992 | 65 | $0 (2021) |
| Insmed, Inc. | $23,182 | 21 | $0 (2022) |
| Mylan Specialty L.P. | $7,537 | 10 | $0 (2022) |
| Advanced Respiratory, Inc | $6,854 | 7 | $0 (2020) |
| Lupin Inc. | $6,588 | 2 | $0 (2021) |
| Electromed, Inc. | $2,379 | 1 | $0 (2019) |
| Shionogi Inc | $950.00 | 1 | $0 (2022) |
| Chiesi USA, Inc. | $930.34 | 6 | $0 (2019) |
| CIPLA USA INC. | $850.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $7,370 | 8 | Insmed, Inc. ($6,293) |
| 2021 | $30,117 | 17 | Gilead Sciences, Inc. ($16,740) |
| 2020 | $19,902 | 19 | Advanced Respiratory, Inc ($6,829) |
| 2019 | $56,686 | 75 | Gilead Sciences, Inc. ($33,764) |
| 2018 | $41,533 | 79 | Gilead Sciences, Inc. ($22,079) |
| 2017 | $29,317 | 41 | Gilead Sciences Inc ($28,870) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2022 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,850.00 | General |
| 11/02/2022 | Mylan Specialty L.P. | Tobi Podhaler (Drug) | Food and Beverage | In-kind items and services | $111.18 | General |
| Category: Aminoglycosides | ||||||
| 10/17/2022 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 10/15/2022 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $72.71 | General |
| 10/15/2022 | Insmed, Inc. | — | Food and Beverage | In-kind items and services | $20.58 | General |
| 05/19/2022 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $950.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/15/2022 | Genentech USA, Inc. | Pulmozyme (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Virology & Specialty Care | ||||||
| 01/07/2022 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: Respiratory | ||||||
| 11/17/2021 | Insmed, Inc. | — | Consulting Fee | In-kind items and services | $2,200.00 | General |
| 11/09/2021 | Mylan Specialty L.P. | TOBI Podhaler (Drug) | Food and Beverage | In-kind items and services | $99.59 | General |
| Category: Aminoglycosides | ||||||
| 10/08/2021 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 10/06/2021 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $222.50 | General |
| 09/08/2021 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $8,300.00 | General |
| 09/02/2021 | Insmed, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,025.00 | General |
| 08/25/2021 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $222.50 | General |
| 08/17/2021 | Insmed, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| 08/09/2021 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 08/06/2021 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 08/04/2021 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $222.50 | General |
| 05/05/2021 | Gilead Sciences, Inc. | Cayston (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: RESP | ||||||
| 04/22/2021 | Lupin Inc. | — | Consulting Fee | Cash or cash equivalent | $5,525.00 | General |
| 04/02/2021 | Gilead Sciences, Inc. | Cayston (Drug) | Consulting Fee | Cash or cash equivalent | $4,140.00 | General |
| Category: RESP | ||||||
| 03/18/2021 | Hill-Rom Company, Inc | The Vest System 205 Acute Care (Device), The Vest System Model 105 Home Care | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: Airway Clearance Device | ||||||
| 03/12/2021 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 03/02/2021 | Insmed, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $510.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NONE | Chiesi USA, Inc. | $425.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 222 | 331 | $162,417 | $27,117 |
| 2021 | 6 | 222 | 376 | $187,580 | $35,081 |
| 2020 | 7 | 246 | 425 | $195,140 | $30,307 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 92 | 122 | $44,502 | $8,763 | 19.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 56 | 78 | $41,452 | $7,503 | 18.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 85 | $45,139 | $6,714 | 14.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $14,460 | $1,582 | 10.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $9,164 | $1,433 | 15.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 20 | $7,700 | $1,122 | 14.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 101 | 185 | $95,110 | $20,228 | 21.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 25 | 86 | $46,182 | $6,749 | 14.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 53 | 60 | $21,760 | $3,762 | 17.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 15 | 15 | $10,740 | $2,022 | 18.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 16 | 16 | $10,316 | $1,510 | 14.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 12 | 14 | $3,472 | $808.57 | 23.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 31 | 146 | $76,066 | $10,785 | 14.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 80 | 121 | $43,089 | $7,151 | 16.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 50 | 65 | $32,770 | $4,734 | 14.4% |
| 99358 | Prolonged patient service without direct patient contact first hour | Facility | 2020 | 28 | 29 | $16,791 | $2,378 | 14.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 29 | 35 | $8,312 | $2,151 | 25.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 17 | 17 | $12,172 | $2,101 | 17.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 11 | 12 | $5,940 | $1,005 | 16.9% |
About Dr. Elliott Dasenbrook, MD
Dr. Elliott Dasenbrook, MD is a Internal Medicine healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780772632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elliott Dasenbrook, MD has received a total of $184,924 in payments from pharmaceutical and medical device companies, with $7,370 received in 2022. These payments were reported across 239 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($96,449).
As a Medicare-enrolled provider, Dasenbrook has provided services to 690 Medicare beneficiaries, totaling 1,132 services with total Medicare billing of $92,504. Data is available for 3 years (2020–2022), covering 19 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Cleveland, OH
- Active Since 10/10/2006
- Last Updated 06/28/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780772632
Products in Payments
- Cayston (Drug) $27,703
- The Vest System 205 Acute Care (Device) $7,611
- TOBI (Drug) $7,318
- Arikayce (Drug) $3,596
- TRIKAFTA (Drug) $2,448
- SMARTVEST (Device) $2,379
- Fetroja (Drug) $950.00
- 4 (Drug) $850.00
- KALYDECO (Drug) $667.50
- SYMDEKO (Drug) $345.89
- PERTZYE (Drug) $293.82
- Creon (Drug) $224.62
- BETHKIS (Drug) $211.52
- Tobi Podhaler (Drug) $111.18
- TOBI Podhaler (Drug) $107.48
- The Monarch Airway Clearance System (Device) $42.61
- Pulmozyme (Biological) $15.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cleveland
C Martin Harris, Md, MD
Internal Medicine — Payments: $1.1M
Marina Magrey, Md, MD
Internal Medicine — Payments: $491,321
Dr. Moshe Ornstein, Md Ma, MD MA
Internal Medicine — Payments: $250,140
Dr. Katherine Talcott, M.d, M.D
Internal Medicine — Payments: $248,994
Syed Bukhari
Internal Medicine — Payments: $164,516
Dr. Leslie Tolle, M.d, M.D
Internal Medicine — Payments: $163,187